Adverum Biotech
Seung Kim is a skilled IT professional with extensive experience in infrastructure and security management. Currently serving as a Senior Analyst at Adverum Biotechnologies, Inc. since May 2021, Seung Kim has previously held significant roles at Intarcia Therapeutics, Inc., where responsibilities included managing end-user devices as a BTG Product Manager for Colleague Compute and improving desktop security and automation processes. Earlier experience includes a position as Senior Helpdesk at BabyCenter, LLC, where Seung Kim successfully implemented and managed system deployment tools and security measures. Seung Kim's educational background includes studies at San Jose State University and De Anza College.
This person is not in any offices
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.